Search Results - "Aya Nakaya"

Neutrophil-to-lymphocyte ratio as an early marker of outcomes in patients with advanced non-small-cell lung cancer treated with nivolumab by Nakaya, Aya, Kurata, Takayasu, Yoshioka, Hiroshige, Takeyasu, Yuki, Niki, Maiko, Kibata, Kayoko, Satsutani, Naoko, Ogata, Makoto, Miyara, Takayuki, Nomura, Shosaku

“…Background There is an unmet need to identify markers that predict the response to nivolumab in patients with non-small-cell lung cancer (NSCLC). The…”
Get full text

Venetoclax Combined with Azacytidine Can Be a First-line Treatment Option for Elderly Blastic Plasmacytoid Dendritic Cell Neoplasm by Nagate, Yasuhiro, Nakaya, Aya, Kamimura, Ren, Hirose, Yumiko, Nojima, Satoshi, Fujita, Jiro, Kiyohara, Eiji, Shibayama, Hirohiko

“…An 84-year-old Japanese man was diagnosed with blastic plasmacytoid dendritic cell neoplasm (BPDCN). We administered combination therapy using venetoclax and…”
Get full text

Associations between acute GVHD-related biomarkers and endothelial cell activation after allogeneic hematopoietic stem cell transplantation by Nomura, Shosaku, Ishii, Kazuyoshi, Fujita, Shinya, Nakaya, Aya, Satake, Atsushi, Ito, Tomoki

“…Hematopoietic stem cell transplantation (HSCT) can cause serious transplant-related complications such as graft-versus-host disease (GVHD). Acute GVHD (aGVHD)…”
Get full text

Primary dural high grade B cell lymphoma mimicking subdural hematoma by Nakaya, Aya, Ishii, Kazuyoshi, Nomura, Shosaku

Get full text

Six Cases of Autoimmune Acquired Coagulation Factor VIII Deficiency: Single Center Experience in Japan by Konishi, Akiko, Nakaya, Aya, Ishii, Kazuyoshi, Nomura, Shosaku

“…We report six cases of autoimmune acquired coagulation factor VIII deficiency, which is a rare bleeding disorder. It is an autoimmune disease, however, there…”
Get full text

Retrospective analysis of plasmacytoma in Kansai Myeloma Forum Registry by Nakaya, Aya, Tanaka, Hirokazu, Yagi, Hideo, Ohta, Kensuke, Shibayama, Hirohiko, Kohara, Takae, Kanda, Junya, Shindo, Maki, Shimura, Yuji, Kosugi, Satoru, Kida, Toru, Kaneko, Hitomi, Imada, Kazunori, Karasuno, Takahiro, Matsuda, Mitsuhiro, Iida, Masato, Adachi, Yoko, Fuchida, Shin-ichi, Uoshima, Nobuhiko, Uchiyama, Hitoji, Takahashi, Ryoichi, Matsui, Toshimitsu, Wada, Katsuya, Kiyota, Miki, Shimazaki, Chihiro, Hino, Masayuki, Kuroda, Junya, Kanakura, Yuzuru, Takaori-Kondo, Akifumi, Nomura, Shosaku, Matsumura, Itaru

“…We retrospectively analyzed 51 patients with solitary plasmacytoma diagnosed from October 2002 to September 2018 from a cohort of 3575 patients with plasma…”
Get full text

Delayed HBV reactivation in Rituximab-containing chemotherapy: How long should we continue anti-virus prophylaxis or monitoring HBV-DNA? by Nakaya, Aya, Fujita, Shinya, Satake, Atsushi, Nakanishi, Takahisa, Azuma, Yoshiko, Tsubokura, Yukie, Hotta, Masaaki, Yoshimura, Hideaki, Ishii, Kazuyoshi, Ito, Tomoki, Nomura, Shosaku

“…Highlights • Reactivation of HBV infection is potentially fatal complication treated with Rituximab. • There is no consensus over what time period antiviral…”
Get full text

Efficacy and safety of anagrelide as a first‐line drug in cytoreductive treatment‐naïve essential thrombocythemia patients in a real‐world setting by Ito, Tomoki, Hashimoto, Yoshinori, Tanaka, Yasuhiro, Nakaya, Aya, Fujita, Shinya, Satake, Atsushi, Nakanishi, Takahisa, Konishi, Akiko, Hotta, Masaaki, Yoshimura, Hideaki, Ishii, Kazuyoshi, Hashimoto, Akiko, Kondo, Toshinori, Omura, Hiromi, Shinzato, Isaku, Tanaka, Takayuki, Nomura, Shosaku

“…Objective This study aimed to retrospectively assess the efficacy and safety of anagrelide in cytoreduction therapy‐naïve essential thrombocythemia (ET)…”
Get full text

Outcomes of ixazomib/lenalidomide/dexamethasone for multiple myeloma: A multicenter retrospective analysis by Takakuwa, Teruhito, Yamamura, Ryosuke, Ohta, Kensuke, Kaneko, Hitomi, Imada, Kazunori, Nakaya, Aya, Fuchida, Shin‐ichi, Shibayama, Hirohiko, Matsuda, Mitsuhiro, Shimazu, Yutaka, Adachi, Yoko, Kosugi, Satoru, Uchiyama, Hitoji, Tanaka, Hirokazu, Hanamoto, Hitoshi, Shimura, Yuji, Kanda, Junya, Onda, Yoshiyuki, Uoshima, Nobuhiko, Yagi, Hideo, Yoshihara, Satoshi, Hino, Masayuki, Shimazaki, Chihiro, Takaori‐Kondo, Akifumi, Kuroda, Junya, Matsumura, Itaru, Kanakura, Yuzuru, Nomura, Shosaku

“…Objectives This study aimed to investigate real‐world data of ixazomib plus lenalidomide and dexamethasone (IRd) therapy for patients with relapsed and…”
Get full text

Treatment of patients with COVID-19 on hemodialysis: Efficacy of remdesivir by Nakaya, Aya, Kondo, Morihiro, Ogura, Eiji, Katayama, Yuki, Yoshino, Eiko, Hozumi, Kazuya, Tago, Saori, Teranishi, Yuko, Minamibashi, Yuki, Harada, Makiko, Kawano, Yuri, Arai, Yuka, Kobayashi, Mika, Kouyama, Airi, Yoshida, Keno, Shimizu, Shozo, Ogura, Kazuma, Iwashita, Katsuaki

Get full text

Comparison of starting doses of anagrelide as a first-line therapy in patients with cytoreductive therapy-naïve essential thrombocythemia: difference between starting at 0.5 and 1.0 mg/day by Hashimoto, Yoshinori, Ito, Tomoki, Tanaka, Yasuhiro, Nakaya, Aya, Fujita, Shinya, Satake, Atsushi, Nakanishi, Takahisa, Konishi, Akiko, Hotta, Masaaki, Yoshimura, Hideaki, Ishii, Kazuyoshi, Hashimoto, Akiko, Kondo, Toshinori, Omura, Hiromi, Shinzato, Isaku, Tanaka, Takayuki, Nomura, Shosaku

“…Anagrelide is widely used for cytoreductive therapy in patients with essential thrombocythemia who are at high risk for thrombosis. The recommended starting…”
Get full text

Real-world effectiveness and safety analysis of carfilzomib–lenalidomide–dexamethasone and carfilzomib–dexamethasone in relapsed/refractory multiple myeloma: a multicenter retrospective analysis by Onda, Yoshiyuki, Kanda, Junya, Kaneko, Hitomi, Shimura, Yuji, Fuchida, Shin-ichi, Nakaya, Aya, Itou, Tomoki, Yamamura, Ryosuke, Tanaka, Hirokazu, Shibayama, Hirohiko, Shimazu, Yutaka, Uchiyama, Hitoji, Yoshihara, Satoshi, Adachi, Yoko, Matsuda, Mitsuhiro, Hanamoto, Hitoshi, Uoshima, Nobuhiko, Kosugi, Satoru, Ohta, Kensuke, Yagi, Hideo, Kanakura, Yuzuru, Matsumura, Itaru, Hino, Masayuki, Nomura, Shosaku, Shimazaki, Chihiro, Takaori-Kondo, Akifumi, Kuroda, Junya

“…Background: Little is known about the real-world survival benefits and safety profiles of carfilzomib–lenalidomide–dexamethasone (KRd) and…”
Get full text

Retrospective multi-center study of Adolescent and Young Adult (AYA) Multiple Myeloma in Kansai Myeloma Forum registry by Nakaya, Aya, Kohara, Takae, Shibayama, Hirohiko, Onda, Yoshiyuki, Kanda, Junya, Kaneko, Hitomi, Imada, Kazunori, Kida, Toru, Kosugi, Satoru, Ishikawa, Jun, Yamamura, Ryosuke, Shimazu, Yutaka, Tanaka, Hirokazu, Fuchida, Shin-ichi, Shimura, Yuji, Kiyota, Miki, Wada, Katsuya, Ito, Tomoki, Uoshima, Nobuhiko, Yagi, Hideo, Yoshihara, Satoshi, Ohta, Kensuke, Shimazaki, Chihiro, Hino, Masayuki, Takaori-Kondo, Akifumi, Kuroda, Junya, Matsumura, Itaru, Kanakura, Yuzuru, Nomura, Shosaku

“…We retrospectively analyzed the clinical features and outcomes in a real-world cohort of adolescents and the young adult (AYA) patients (age between 16 and 39…”
Get full text

Pomalidomide with or without dexamethasone for relapsed/refractory multiple myeloma in Japan: a retrospective analysis by the Kansai Myeloma Forum by Matsumura-Kimoto, Yayoi, Kuroda, Junya, Kaneko, Hitomi, Kamitsuji, Yuri, Fuchida, Shin-ichi, Nakaya, Aya, Shibayama, Hirohiko, Uoshima, Nobuhiko, Yokota, Isao, Uchiyama, Hitoji, Yagi, Hideo, Kosugi, Satoru, Matsui, Toshimitsu, Ishikawa, Jun, Matsuda, Mitsuhiro, Ohta, Kensuke, Iida, Masato, Tanaka, Hirokazu, Kobayashi, Masayuki, Wada, Katsuya, Shimazaki, Chihiro, Nomura, Shosaku, Imada, Kazunori, Hino, Masayuki, Matsumura, Itaru, Kanakura, Yuzuru, Takaori-Kondo, Akifumi

“…Determinants of the efficacy and safety of pomalidomide (POM) monotherapy or POM plus dexamethasone (DEX) (POM/DEX) for relapsed and refractory multiple…”
Get full text

Hiccups as a specific neurological manifestation in males with COVID-19 by Nakaya, Aya, Ogura, Eiji, Katayama, Yuki, Yoshii, Masami, Yoshino, Eiko, Hozumi, Kazuya, Tago, Saori, Teranishi, Yuko, Minamibashi, Yuki, Harada, Makiko, Yoshioka, Mami, Kawano, Yuri, Arai, Yuka, Yoshida, Keno, Shimizu, Shozo, Ogura, Kazuma, Iwashita, Katsuaki

“…Several clinical manifestations of COVID-19 have been reported in the literature since then. In addition to upper respiratory symptoms, dysgeusia and anosmia…”
Get full text

Impact of cytogenetic abnormalities in symptomatic multiple myeloma; a Japanese real-world analysis from Kansai Myeloma Forum by Nakaya, Aya, Shibayama, Hirohiko, Uoshima, Nobuhiko, Yamamura, Ryosuke, Yoshioka, Satoshi, Imada, Kazunori, Shimura, Yuji, Hotta, Masaaki, Matsui, Toshimitsu, Kosugi, Satoru, Hanamoto, Hitoshi, Uchiyama, Hitoji, Yoshihara, Satoshi, Fuchida, Shin-Ichi, Onda, Yoshiyuki, Tanaka, Yasuhiro, Ohta, Kensuke, Matsuda, Mitsuhiro, Kanda, Junya, Yoko, Adachi, Kiyota, Miki, Kawata, Eri, Takahashi, Ryoichi, Fukushima, Kentaro, Tanaka, Hirokazu, Yagi, Hideo, Takakuwa, Teruhito, Hosen, Naoki, Ito, Tomoki, Shimazaki, Chihiro, Takaori-Kondo, Akifumi, Kuroda, Junya, Matsumura, Itaru, Hino, Masayuki

“…To evaluate the specific prognostic value of CAs, we conducted an analysis of 923 symptomatic multiple myeloma patients. Among this cohort, 480 patients had…”
Get full text

Neutrophil-to-lymphocyte ratio (NLR) fails to predict outcome of diffuse large B cell lymphoma by Azuma, Yoshiko, Nakaya, Aya, Fujita, Shinya, Satake, Atsushi, Nakanishi, Takahisa, Tsubokura, Yukie, Saito, Ryo, Konishi, Akiko, Hotta, Masaaki, Yoshimura, Hideaki, Ishii, Kazuyoshi, Ito, Tomoki, Nomura, Shosaku

“…Neutrophil-to-lymphocyte ratio (NLR) has been recognized as a poor prognostic indicator in various solid tumors. We retrospectively analyzed 530 patients with…”
Get full text

Localized lymphadenopathy with myelodysplastic syndrome associated with tuberculosis by Nakaya, Aya, Ishii, Kazuyoshi, Shimizu, Toshiki, Tamaki, Takeshi, Ishiura, Yoshihisa, Inaba, Mayumi, Uemura, Yoshiko, Nakamine, Hirokazu, Nomura, Shosaku

“…We report the case of a man who developed myelodysplastic syndrome (MDS) and refractory cytopenia of unilineage dysplasia, 5 months after aortic valve…”
Get full text

Successful treatment with mogamulizumab followed by allogeneic hematopoietic stem-cell transplantation in adult T-cell leukemia/lymphoma: a report of two cases by Tsubokura, Yukie, Satake, Atsushi, Hotta, Masaaki, Yoshimura, Hideaki, Fujita, Shinya, Azuma, Yoshiko, Nakanishi, Takahisa, Nakaya, Aya, Ito, Tomoki, Ishii, Kazuyoshi, Nomura, Shosaku

“…A humanized anti-CC chemokine receptor 4 (CCR4) monoclonal antibody, mogamulizumab (MOG), has been shown to be safe and effective in the treatment of…”
Get full text

A phase II study of bendamustine plus rituximab in Japanese patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma previously treated with rituximab: BRB study by Matsumoto, Kimihiro, Takayama, Nobuyuki, Aisa, Yoshinobu, Ueno, Hironori, Hagihara, Masao, Watanabe, Kentaro, Nakaya, Aya, Chen, Kenko, Shimizu, Takayuki, Tsukada, Yuiko, Yamada, Yuji, Nakazato, Tomonori, Ishida, Akaru, Miyakawa, Yoshitaka, Yokoyama, Kenji, Nakajima, Hideaki, Masuda, Yoshihiro, Yano, Takahiro, Okamoto, Shinichiro

“…To evaluate the efficacy and safety of a combined regimen of bendamustine (B) and rituximab (R) in Japanese patients with relapsed/refractory (r/r) indolent…”
Get full text